HC Wainwright Issues Positive Outlook for Aemetis Earnings

Aemetis, Inc (NASDAQ:AMTX) – Equities research analysts at HC Wainwright raised their Q2 2026 earnings per share estimates for Aemetis in a report released on Monday, May 11th. HC Wainwright analyst A. Dayal now anticipates that the specialty chemicals company will earn ($0.32) per share for the quarter, up from their prior estimate of ($0.49). The consensus estimate for Aemetis’ current full-year earnings is ($1.08) per share. HC Wainwright also issued estimates for Aemetis’ Q3 2026 earnings at ($0.33) EPS, Q4 2026 earnings at ($0.33) EPS, FY2026 earnings at ($1.31) EPS, FY2027 earnings at ($0.36) EPS, FY2028 earnings at $0.27 EPS and FY2029 earnings at $1.64 EPS.

Aemetis (NASDAQ:AMTX) last released its quarterly earnings data on Thursday, May 7th. The specialty chemicals company reported ($0.33) EPS for the quarter, missing analysts’ consensus estimates of ($0.27) by ($0.06). The company had revenue of $54.62 million during the quarter, compared to analysts’ expectations of $66.70 million.

Other equities analysts also recently issued research reports about the company. Ascendiant Capital Markets increased their price target on Aemetis from $20.00 to $21.00 and gave the company a “buy” rating in a report on Wednesday, April 8th. Loop Capital set a $1.75 price target on Aemetis in a report on Thursday, March 12th. Weiss Ratings reiterated a “sell (e+)” rating on shares of Aemetis in a report on Monday, April 20th. Finally, Wall Street Zen downgraded Aemetis from a “hold” rating to a “sell” rating in a report on Saturday. Two investment analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $8.58.

Aemetis Stock Down 3.0%

Shares of AMTX stock opened at $2.25 on Wednesday. Aemetis has a 12 month low of $1.30 and a 12 month high of $3.80. The business’s 50 day moving average is $2.55 and its two-hundred day moving average is $1.97. The company has a market cap of $158.33 million, a PE ratio of -1.89 and a beta of 1.46.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the company. 683 Capital Management LLC bought a new position in Aemetis in the fourth quarter worth $327,000. Qube Research & Technologies Ltd bought a new position in shares of Aemetis during the second quarter valued at $246,000. Bridgeway Capital Management LLC lifted its holdings in shares of Aemetis by 96.3% during the third quarter. Bridgeway Capital Management LLC now owns 101,900 shares of the specialty chemicals company’s stock valued at $229,000 after acquiring an additional 50,000 shares during the period. Bank of America Corp DE lifted its holdings in shares of Aemetis by 62.6% during the third quarter. Bank of America Corp DE now owns 38,526 shares of the specialty chemicals company’s stock valued at $87,000 after acquiring an additional 14,836 shares during the period. Finally, Jump Financial LLC bought a new position in shares of Aemetis during the second quarter valued at $64,000. 27.02% of the stock is owned by institutional investors.

Aemetis Company Profile

Aemetis, Inc, headquartered in Cupertino, California, is a renewable fuels and renewable natural gas producer dedicated to decarbonizing the transportation sector. The company operates two primary business segments: Aemetis Advanced Fuels, which manufactures ethanol, biodiesel and sustainable aviation fuel using patented carbon capture and separation technology; and Aemetis RNG, which develops dairy-based renewable natural gas projects in California for pipeline injection and transportation use.

Since its incorporation in 2006, Aemetis has expanded its production footprint through organic growth and strategic acquisitions.